Eliot Engel actually said...

"I am very troubled by the redesign. I am worried that the redesign will be used as an excuse to cut back."

"How does gutting vital efforts help us get at the root causes of this problem?"

"I was happy to work with Congresswoman McMorris Rodgers to include provisions on biomarker development qualification."

"I feel that there should be formalized, straightforward ways to gauge the safety and efficacy of medical treatments."